Liver Enzymes Reductions From Baseline Over Time in Resmetirom-Treated Patients in a Phase 3 Study, MAESTRO-NASH

Gastroenterol Hepatol (N Y). 2024 Dec;20(12 Suppl 11):14-15.
No abstract available